Search tips
Search criteria 


Logo of nihpaAbout Author manuscriptsSubmit a manuscriptHHS Public Access; Author Manuscript; Accepted for publication in peer reviewed journal;
Free Radic Biol Med. Author manuscript; available in PMC 2010 December 1.
Published in final edited form as:
PMCID: PMC2783357

Remodeling of the tight junction during recovery from exposure to hydrogen peroxide in kidney epithelial cells


Renal ischemia-reperfusion injury results in oxidative stress-induced alterations in barrier function. Activation of the mitogen-activated protein (MAP) kinase pathway during recovery from oxidative stress may be an effector of oxidant-induced tight junction reorganization. We hypothesized that tight junction composition and barrier function would be perturbed during recovery from oxidative stress. We developed a model of short-term H2O2 exposure followed by recovery using Madin Darby Canine Kidney cells (MDCK II). H2O2 perturbs barrier function without a significant cytotoxic effect except in significant doses. ERK-1/2 and p38, both enzymes of the MAP kinase pathway, were activated within minutes of exposure to H2O2. Transient exposure to H2O2 produced a biphasic response in transepithelial electrical resistance (TER). An initial drop in TER at 6 hours was followed by a significant increase at 24 hours. Inhibition of ERK-1/2 activation attenuated the increase in TER observed at 24 hours. Expression of occludin initially decreased followed by partial recovery at 24 hours. In contrast, claudin-1 levels decreased and failed to recover at 24 hours. Claudin-2 levels markedly decreased at 24 hours; however, inhibition of ERK-1/2 activation was protective. Occludin and claudin-1 localization at the apical membrane on immunofluorescent images was fragmented at 6 hours after H2O2 exposure with subsequent recovery of appropriate localization by 24 hours. MDCK II cell recovery after H2O2 exposure is associated with functional and structural modification of the tight junction that are mediated in part by activation of the MAP kinase enzymes, ERK-1/2 and p38.

Keywords: Tight junction, kidney epithelium, oxidative stress, barrier function


The tight junction encircles epithelial cells at the most apical portion of their lateral membranes, forming a barrier between cells and regulating paracellular transport across cell layers. The structure of the tight junction is dynamic and highly complex, consisting of multiple protein strands that join adjacent cell membranes and occupy the intercellular space. The integral transmembrane tight junction proteins include occludin and the claudin family that fundamentally contribute to observed epithelial barrier properties along with the establishment of polarized epithelial membranes [1, 2]. Tight junction disruption has been associated with barrier dysfunction in diseases that involve many different epithelial cell types [3, 4], including as a unifying explanation for the multiple organ dysfunction syndrome seen in sepsis [5].

Normal renal physiology is characterized by controlled reabsorption and secretion of various solutes across renal tubular epithelium. Acute renal failure (ARF) is a common complication suffered by critically ill intensive care patients and often results in severe morbidity and/or mortality [6]. Ischemic ARF is characterized by sublethal and reversible tubular injury resulting in renal tubular dysfunction [4, 7]. A growing body of evidence suggests that ischemia-reperfusion injury induced ARF is a disease of inflammation [8, 9]. Oxidative stress-induced damage and activation of cell signaling cascades lead to the release of inflammatory mediators [10]. Changes at the tight junction induced by oxidative stress may contribute to aberrant ion and solute passage [11]. An association between renal ischemia and tight junction alterations has been demonstrated in multiple studies both in vivo and in vitro[4]. Despite its role in disease, the underlying mechanisms of tight junction injury and repair are still not well understood.

Common models of ARF in vitro include ATP depletion and exposure to nephrotoxic agents that mimic in vivo ischemic tubular injury. However, these models fail to fully explain all effects seen in vivo following ischemia-reperfusion injury [7]. This study addresses the effects of oxidative stress-induced injury to the tight junction in kidney epithelial cells with an emphasis on the reassembly of the tight junction during recovery. Here we present a model of recovery of the tight junction after exposure to the naturally occurring oxidant, hydrogen peroxide (H2O2). We hypothesized that tight junction reassembly and functional recovery following exposure to H2O2 would be mediated by mitogen activated protein (MAP) kinase activation.

Materials and Methods


Flasks, cell culture plates and Costar Transwell plates (Corning) were obtained from Fisher Scientific (Pittsburgh, PA). Hydrogen peroxide solution and fluorescein were purchased from Sigma-Aldrich (St. Louis, MO). U0126, SB202190, and cycloheximide were acquired from EMD Biosciences (San Diego, CA). The lactate dehydrogenase (LDH) activity cytotoxicity kit was purchased from Roche Applied Science (Indianapolis, IN). The caspase-3 assay kit, polyclonal rabbit anti-occludin, anti-claudin-1, and anti-claudin-2, and Alexa 488-conjugated anti-rabbit IgG antibodies were purchased from Invitrogen (Carlsbad, CA). Polyclonal rabbit anti-MAP Kinase 1/2 (ERK 1/2) was purchased from Upstate Cell Signaling Solutions (Lake Placid, NY). Polyclonal rabbit anti-p38 was purchased from Abcam (Cambridge, MA). Horseradish Peroxidase (HRP) conjugated anti-rabbit IgG antibody was purchased from Jackson ImmunoResearch Laboratories (West Grove, PA).

Cell Culture

MDCK Type II (CCL-34) cells were obtained from ATCC (Manassas, VA) and grown in Dulbeco’s Modification of Eagle’s Medium (DMEM) (Mediatech, Herndon, VA), supplemented with 5% fetal bovine serum (FBS), ITS, penicillin (100 U/mL), and streptomycin (100 U/mL) in a humidified incubator at 37°C and 5% CO2. For electrical resistance, flux measurements and immunofluoresent analysis cells were grown on 12-well Costar Transwell plates with 12 mm polycarbonate inserts with a 0.4 μm pore. For protein collection, LDH and Caspase-3 assays cells were grown on 24-well plates.

Experimental Conditions and Treatments

MDCK II cells were grown for 7–10 days to confluency (24-well plates) or until TER was stable for at least 2 days. At this time, cells were exposed to different concentrations of H2O2 (0.5, 3, and 10 mM) in complete DMEM for 60 minutes and then recovered with by changing to fresh media. TER and LDH release were measured and protein was collected at 2, 6, and 24 hours from the start of the exposure. Flux was measured at 6 and/or 24 hours from the start of exposure. Caspase-3 activity samples were collected at 2 and 6 hours after the start of exposure. For the MAP kinase enzyme activation experiments, MDCK II cells were changed to serum free DMEM for 1 hour to minimize serum-related phosphorylation; cells were then exposed to 3 mM H2O2, and protein was collected at various time points during the exposure. For the inhibitor experiments, cells were pre-incubated with the ERK-1/2 activation inhibitor U0126 (10 μM) or the p38 inhibitor SB202190 (10 μM) for 30 minutes prior to H2O2 exposure and fresh inhibitor was added with exposure and recovery media changes.

Determination of Cytotoxicity

LDH release into the media was used as a measure of cytotoxicity or plasma membrane integrity. MDCK II cells were changed to low serum (0.5% FBS) media at the start of treatment to avoid serum interference with the assay. At the indicated time points, media from the apical compartment was collected. An equal volume of assay substrate was added to each sample and absorbance was measured at 492 nm using a SpectraMax250 Platereader (Molecular Devices). A group of cells was lysed with 2% Triton-X 100 ten minutes prior to supernatant collection and used to determine total cellular LDH activity (high control). Untreated, control samples were used as low control. DMEM containing 0.5% FBS was used to determine background absorbance which was subtracted from each sample result. Cytotoxicity was calculated using the following formula: [(experimental sample absorbance − low control absorbance)/(high control absorbance − low control absorbance)] and expressed as percent cytotoxicity versus control.

Caspase-3 activity was used to assess cell death via apoptosis. At the appropriate time points after treatment, MDCK II cells were rinsed with sterile PBS and lysed for 30 minutes on ice. Cell lysate was collected and centrifuged for 5 minutes at 5000 rpm. Supernatant was collected and incubated for 30 minutes at room temperature with caspase-3 substrate. The fluorescence was measured (ex. 495nm and em. 520 nm) using a SpectraMax 250 fluorescence microplate reader (BioTech). Values were normalized for cell lysate protein concentration, as measured by a Spectrophotometer (Nanodrop, model ND-1000).

Measurement of Transepithelial Electrical Resistance (TER)

MDCK II cells were grown on Transwell plates until TER was stable for 2 days after a minimum of seven days in culture. Inserts were transferred aseptically to an Endohm Measurement Chamber and TER was directly measured using an Epithelial Voltohmmeter (World Precision Instruments, Model EVOMX). For testing, Transwells were kept in DMEM media and allowed to come to room temperature. The TER results are expressed as the measured resistance in Ohms multiplied by the surface area of the Transwell membrane.

Permeability Flux Assay

MDCK II cells were grown as described above for TER measurements. Permeability flux assays were performed by applying fluorescein (50 μM) to the apical chamber of Transwell inserts. Samples were collected from the basolateral (100 μL) and the apical (5 μL) compartments 60 minutes after fluorescein application. Apical samples were diluted with DMEM to a final volume of 100 μL. The fluorescent intensity in samples was measured (ex. 485nm and em. 528 nm) using a SpectraMax 250 fluorescence microplate reader (BioTech). The diffusive flux rate (Jo) was calculated with corrections for volume, surface area, and time [12].

Western Blot Analysis

Analysis of protein expression via Western blot analysis was performed as previously described [13]. Protein concentration was determined using a Spectrophotometer (Nanodrop, model ND-1000). Equal concentrations of protein were gel-electrophoresed, followed by transfer to PDVF membranes. Membranes were probed for tight junction proteins or MAP kinase enzymes using a primary antibody concentration of 1:5,000 and a secondary antibody concentration of 1:10,000. The membranes were developed using the SuperSignal WestPico Chemiluminescence kit (Pierce, Rockford, IL) and imaged on a VersaDoc 3000. Bands were quantified with densitometry using the QuantityOne 1-D software (BioRad).

Immunofluorescent Analysis

Following treatment of MDCK II cells grown on Costar Transwells, cell layers were rinsed with sterile PBS on ice for ten minutes. Cells were permeabilized with an actin stabilizing buffer (0.2% Triton-X100, 100 mM KCl, 3 mM MgCl2, 1.3 mM CaCl2, 25 mM sucrose, and 2 mM HEPES, pH 7.1) for 2 min on ice, then fixed with cold 95% ethanol in PBS for 30 min. Cells were rinsed once with PBS and blocked with 5% BSA in PBS for 10 min. They were then incubated at room temperature for 1 hour with tight junction protein-specific primary antibodies [14]. Cells were rinsed three times with PBS and incubated at room temperature with anti-rabbit Alexa 488-conjugated secondary antibodies for 45 min. Primary (1:100) and secondary (1:200) antibodies were diluted in 1% BSA in PBS and centrifuged at 10,000×g for 15 min at 4°C prior to incubation. Following extensive rinse steps, the Transwell membranes were excised, coated with anti-fade medium, placed onto microscope slides, and stored in the dark until microscopic analysis using a Nikon 2000E microscope fitted with a z-stepper motor and MetaMorph Image Analysis Software.


Data were analyzed with the StatPlus software package using either 1-way analysis of variance (ANOVA) followed by a protected Bonferroni Test for Differences Between Means or 2-way ANOVA followed by a protected Scheffe contrasts among pairs of means. A p value < 0.05 was considered significant, n indicates the number independent experiments. Errors are reported as SEM.


A model of H2O2 exposure and recovery was developed

MDCK II cells grown on Transwell plates with stable TER (~100 Ω*cm2) were exposed to various concentrations of H2O2 for 1 hour then recovered for 24 hours. There was no effect on TER during the 24 hour recovery after exposure to 0.5 mM H2O2. Recovery after both the 3 mM and 10 mM dose of H2O2 exposure resulted in a biphasic TER response. An initial decrease in TER occurred at 2 and 6 hours (40% decrease), followed by a marked increase at 24 hours after exposure (3–4 fold increase) (Fig 1A). Fluorescein flux rate measured at the 24 hour timepoint was not significantly perturbed by either the 0.5 mM or 3 mM H2O2 doses compared to control. However, a significant elevation in fluorescein flux was observed following exposure to 10 mM H2O2 (Figure 1B). Cytotoxicity, as measured by LDH release, was low and not significantly different from control except for at 24 hours after 10 mM H2O2 exposure (Figure 1C).

Figure 1
Functional changes in MDCK II cells during recovery from H2O2 exposure. CRTL indicates MDCK II cells cultured under identical conditions that were not exposed to H2O2. Transepithelial Electrical Resistance (TER) response was measured in MDCK cells during ...

Inhibition of ERK-1/2 activation during recovery from H2O2 exposure enhances Caspase-3 activation

Inhibition of ERK activation with U0126 resulted in a significant and marked increase in caspase-3 activity at 6 hours when compared to vehicle control, antagonist alone and H2O2 exposed cells, thus demonstrating the importance of ERK activation in cell survival responses (Figure 2). Additionally, caspase-3 levels were significantly elevated over time in the H2O2 group at 6 hours when compared with the 2 hour measurement.

Figure 2
ERK inhibition potentiates caspase-3 activity during recovery from H2O2 exposure. Cells were grown in 24-well culture plates and exposed to 3mM H2O2 for 60 minutes, then recovered for up to 6 hours. U0126 (10μM) was added 30 minutes prior to H ...

The biphasic functional response during recovery is dependent on new protein synthesis

In order to examine the requirement for new protein synthesis during junctional remodeling, the protein synthesis inhibitor cycloheximide (CHX, 10 μM) was employed. MDCK II cells exposed to 3 mM H2O2 in the presence of CHX for the entire protocol resulted in a significant decrease in TER at 6 and 24 hours in contrast to the marked increase in TER at 24 hours seen with H2O2 alone. In contrast, CHX addition at the 6 hour interval after H2O2 exposure resulted in TER returning to control levels at the 24 hour time point (Figure 3). Addition of CHX alone did not alter TER over the 24 hour period (data not shown).

Figure 3
Effects of cycloheximide (CHX) on functional recovery after H2O2 exposure. Cells were grown in 12-well transwells and exposed 3 mM H2O2 for 60 minutes then recovered for 24 hours. CHX (10 μM) was added either with exposure or at 6 hours after ...

Tight junction protein expression changes in response to H2O2 exposure and recovery

Exposure to 3 mM H2O2 followed by recovery resulted in decreased occludin protein levels at 2 and 6 hours (both 70% of control levels) with a relative increase towards baseline levels at 24 hours (Figure 4A). Interestingly, a higher molecular weight occludin band was observed at the 2-hour interval consistent with previously studies indicating occludin was highly phosphorylated [15]. Addition of the ERK antagonist was occludin protective at the 6-hour interval but had no effect on expression at 24 hours since occludin levels had recovered. Claudin-1 levels were decreased at 2 hours with a further and sustained depression at 6 hours and 24 hours (Figure 4B). ERK inhibition did not influence the claudin-1 response to H2O2. Claudin-2 levels were markedly decreased at 24 hours after exposure to H2O2 (Figure 4C). ERK inhibition was claudin-2 protective at the 24-hour interval. β-actin (Figure 4D) levels were not significantly altered by the given treatments.

Figure 4
Expression of Tight Junction proteins during recovery from H2O2 exposure. Cells were exposed to 3 mM H2O2 for 60 minutes then recovered. Total protein was collected at indicated time points. Panel (A) is densitometric analysis of the occludin content ...

Tight junction protein localization changes in response to H2O2 exposure and recovery

Tight junction protein localization was determined using indirect immunofluorescence (Figure 5). MDCK II cells in the control condition displayed the expected chicken-wire tight junction protein localization pattern. Exposure to 3 mM H2O2 followed by recovery resulted in a substantial delocalization of the tight junction proteins occludin and claudin-1 at 6 hours. By 24 hours after exposure, occludin localization had returned to near-normal, while claudin-1 localization was recovering but appeared delayed in comparison to the occludin response which is consistent with the expression data. Claudin-2 localization appears not to be markedly impacted by H2O2 exposure however an increase in membrane ruffling is observed at 24 hours (Figure 5).

Figure 5
Indirect immunofluorescence of occludin, claudin-1, and claudin-2 localization. MDCK II cells grown on Transwells were exposed to 3mM H2O2 for 60 minutes, then recovered for 6 and 24 hours. A. Cells were then fixed, permeabilized, and probed for occludin, ...

The MAP kinase enzymes ERK-1/2 and p38 are activated by H2O2 exposure

Phosphorylated (activated) ERK-1/2 levels are typically low in MDCK II cells. Exposure to 3 mM H2O2 resulted in rapid and time-dependent manner increase in phosphorylated ERK-1/2 for up to 60 minutes of exposure (Figure 6A). Phosphorylated (activated) p38 levels were robustly elevated over time with exposure to 3 mM H2O2; similarly, there were low-levels of phosphorlylated p38 in control cells (Figure 6B). We have confirmed that the ERK-1/2 activation inhibitor U0126 (10 μM) completely blocks detection of phosphorylated ERK-1/2. The p38 inhibitor, SB202190 (10 μM) attenuates phosphorylated p38 in our cell system. However, it should be noted that the SB202190 does not block the activity of the upstream kinase but is rather a specific antagonist of p38 activity including inhibition of autophosphorylation [16, 17]. Additionally, we have demonstrated that U0126 partially attenuates p38 phosphorylation, but SB202190 does not interfere with ERK-1/2 phosphorylation (Figure 6C).

Figure 6
H2O2 exposure rapidly activates the MAP kinase enzymes ERK-1/2 and p38. Confluent MDCK II cells were exposed to 3mM H2O2 in serum free media, and total protein was collected at indicated time points. Panel (A) is densitometric analysis of the phospho-ERK ...

Inhibition of ERK-1/2 activation and p38 activity alters the functional changes seen during recovery from H2O2 exposure

Inhibiting ERK activation significantly attenuated the increase in TER seen at 24 hours following H2O2 exposure. In contrast, inhibiting p38 activity with SB202190 potentiated the TER response when compared to the H2O2 exposure alone (Figure 7A). MAP kinase antagonist (U0126 or SB202190) treatment alone had no effect on TER over the same time period (data not shown). Paracellular flux rates at the 6 hour time point were elevated in all the H2O2 exposed groups, and SB202190 potentiated the increase flux when compared to the H2O2 exposure alone. Flux rates at the 24 hour time point in the H2O2 exposed groups were similar to control levels (Figure 7B).

Figure 7
Functional changes in MDCK II cells are altered by the ERK inhibitor U0126 and p38 inhibitor SB202190 during recovery from H2O2 exposure. Cells were grown in 12-well transwells and exposed to 3mM H2O2 for 60 minutes, then recovered for 24 hours. Inhibitors ...


Redox signaling by reactive oxygen species, including H2O2, has been demonstrated in many cell types during normal cell functions, as well as pathologic disease states [1820]. ERK activation is known to exert pleiotropic effects on cellular systems including participation in regulating responses to H2O2 exposure. Cell type and H2O2 exposure parameters influence the responses, along with a complex system of differential activity by protein tyrosine phosphatases and kinases by the oxidation of well-conserved catalytic cysteine residues [18, 21]. This study was designed to examine the relationship between MAP kinase activation and tight junction dynamics during recovery from oxidative stress in MDCK II cells. In addition to the kidney, our results have important clinical relevance to other organ systems such as the brain and lung where the existence of various tight junction proteins have been recently described and oxidative stress is known to be an important cause of injury in both adults and the developing human [2224]

Flux is a dynamic measure of solute permeability influenced by tight junction strand remodeling and cytoskeletal events that reflects a different picture of junctional function than TER [25]. A previous study in MDCK II cells demonstrated a decrease in TER in response to H2O2 exposure, which was associated with tight junction protein disorganization. Reassembly of the junction during recovery was shown to be dependent on tyrosine phosphorylation [26]. In the current study, we demonstrate that TER has a biphasic response to H2O2 exposure and recovery. The initial decrease correlates with elevated paracellular flux findings, consistent with increased permeability of the junction to water and solutes, including ions. The substantial elevation in TER at the later interval suggests an altered tight junction composition with significantly decreased ionic permeability. Paracellular flux is initially elevated during the first phase of recovery period but then returns to normal levels at later intervals suggesting a structurally disrupted tight junction that recovers, which is consistent with the immunofluorescence findings. Further investigation into the mechanisms involved with recovery of TER and cellular barrier function, including MAP kinase regulation and altered expression of various key tight junction proteins, may potentially lead to more effective therapeutic strategies to prevent or limit cellular injury. For example, such future experiments would provide valuable insights into understanding the role of tight junctions in blood-brain barrier injury following hypoxic-ischemic insult given that little is currently understood in this area [27].

An area of interest is ascertaining whether ERK activation is beneficial or detrimental to cell survival [28]. For instance, constitutively active MEK, an upstream activator of ERK, has been shown to provide resistance to H2O2 exposure [29]. In contrast, a recent study using renal proximal tubular cells showed that ERK activation due to H2O2 exposure is associated with increased mitochondrial permeability and necrosis [30]. We find that inhibition of ERK activation during exposure to H2O2 and the subsequent recovery interval significantly elevated caspase-3 activity when compared to caspase-3 activity in the H2O2-group. This suggests that ERK activity during an acute oxidative stress event is anti-apoptotic in MDCK II cells.

In the present study, we examined the role of protein synthesis on the TER response during recovery from H2O2 exposure by employing cycloheximide treatment. We found that protein synthesis was required for recovery from H2O2 exposure. Interestingly, the marked elevation in TER during the later phase of recovery was dependent on de novo protein synthesis. In contrast to our findings, Meyer et. al. suggested that tight junction recovery was not dependent on new protein synthesis, as evidenced by no change in the recovery patterns with cycloheximide treatment [26]. Of note, they used both a shorter H2O2 exposure time (30 minutes) and recovery period (8 hours) in their experiments, which at least in part may have accounted for the difference in results.

We report that occludin expression and localization is dynamically regulated in response to H2O2 exposure and recovery. Occludin was the first transmembrane protein described as a component of the tight junction [31] and alterations in occludin in initial studies appeared to affect tight junction function. However, occludin −/− mice develop structurally and functionally normal tight junctions [32], and there is now considerable evidence that the claudin super-family of tight junction proteins confer the tissue-specific differences in resistance and charge-selectivity [33]. Although the contribution of occludin to barrier function remains to be further elucidated, occludin does also appear to be involved in the cell-signaling function of the tight junction [3335]. As such, it is interesting that in our model of recovery from oxidative stress, occludin expression and localization is initially disrupted, but then recovers by 24 hours. Although these changes in expression and localization may not be responsible for the demonstrated functional changes, it is possible that these changes in occludin play a role in transmission of the cell-signaling events induced by H2O2 exposure. Basuroy et. al. showed that H2O2–mediated barrier dysfunction in an intestinal epithelial cell line is in part secondary to the rapid phosphorylation of occludin. The study also demonstrated that epidermal growth factor prevents H2O2–mediated barrier dysfunction in what appears to be an ERK-1/2 mediated pathway. In addition, phospho-ERK appeared to be co-localized with occludin, providing evidence that ERK-1/2 plays a role in the regulation of tight junction proteins [36]. Consistent with an occludin phosphorylation event [15] our study showed a higher mobility occludin band during the early phase of recovery and ERK inhibition was occludin protective. A study in MDCK cells transfected with mutant occludin demonstrated a similar uncoupling of flux and TER. However, this effect occurred in an opposite manner, as occludin overexpression caused an increase in flux, but no apparent change in TER [25]. In accordance with previous studies the changes in occludin expression and localization that occur during recovery from H2O2 exposure likely contribute to the uncoupling of the flux and TER responses during the later phases of recovery.

Activation of ERK-1/2 is integral to the regulation of paracellular permeability in MDCK cells [37, 38], and ERK-1/2 regulation of H2O2-mediated tight junction permeability has been established in multiple cell types [36, 39, 40]. Consistent with these previous studies, we have demonstrated that ERK-1/2 is rapidly activated upon H2O2 exposure. Lipschutz et. al. demonstrated that transfection of MDCK Type II cells with activated ERK-1/2 causes a decrease in claudin-2 levels and an increase in TER [38], which is consistent with our results. Claudin-2 creates cation-specific pores in the tight junction generating a low resistance phenotype, TER in is inversely related to claudin-2 levels in MDCK cells [41, 42]. The phenomenon of elevated TER during the recovery phase after exposure to H2O2 has not previously been reported. We propose that de novo protein expression in addition to ERK-1/2 activation is required to lower claudin-2 levels generating the marked changes in observed TER.

The initial identification of p38 MAP kinase demonstrated it was tyrosine phosphorylated in response to bacterial endotoxin and hyperosmolarity [43]. In an independent investigation it was also established that SB202190 and other similar compounds blocked cytokine production by inhibiting cytokine-suppressive antiinflammatory drug-binding protein now known as p38 [44]. The p38 family plays a central role in the response to a variety of stressors and is an essential component of numerous cellular signaling cascades [45]. Focusing on p38 and barrier function it has been demonstrated that p38 was activated in endothelial cells in response to H2O2 and inhibition of p38 activity was barrier protective [46]. In Caco-2 cells a model of colonic epithelium, H2O2 activated p38 resulting in a compromised barrier function, both inhibitors of p38 or overexpression of a p38 repressor (Wip1) was junction protective [47]. Activation of p38 following H2O2 exposure was necessary for EGF receptor activation and beta-catenin phosphorylation in renal proximal tubular cells. The p38 activity resulted in a cellular dediferentiation that is essential for tissue repair and remodeling during renal injury [48, 49]. In the current study, we demonstrate rapid phosphorylation of p38 following H2O2 exposure. Inhibition of p38 activity using SB202190 resulted in a significant elevation of paracellular flux during the first phase of recovery when compared to the H2O2-group alone. Interestingly, p38 inhibition potentiated the TER response at 24 hours in contrast to ERK inhibition.

In summary, we report a novel model of recovery from exposure to oxidative stress in a kidney epithelial cell line. The model presented demonstrates that MAP kinase activation alters both the structure and function of the tight junction following exposure to H2O2, which is a naturally occurring oxidant that has been implicated in oxidative stress-induced damage to renal tubular epithelium during ischemic ARF. Dynamic changes in occludin, claudin-1 and claudin-2 expression and localization contribute to the functional changes observed during recovery from H2O2 exposure. Importantly, reassembly of the junction that occurs during recovery results in a modified tight junction composition produced lasting functional consequences, which potentially alters the physiology of the tissue. This study adds to the growing body of evidence that injury of the tight junction in renal tubular epithelial cells contributes to the pathophysiology of ARF and that remodeling and repair of tight junction proteins is important for subsequent clinical recovery of renal function. In addition, future investigation into the role of tight junction proteins in injury and repair in other organ systems to include the brain, gastrointestinal tract and lung following insults such as oxidative stress will be important and may ultimately lead to more effective clinical therapies,


This work was supported in part by National Institutes of Health Grant DK065652. The authors would like to thank Christopher L. Koehler for his contribution to this project. In addition, the authors would like to thank the Trinity University Department of Biology and the United States Air Force for their generous support of this project.


junctional adhesion molecule
acute renal failure
lactate dehydrogenase
transepithelial electrical resistance
hydrogen peroxide
mitogen activated protein



The views and opinions expressed in this manuscript are those of the authors and do not reflect the official policy or position of the Air Force Medical Department, Department of the Air Force, the Department of Defense, or the United States Government.

Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.


1. Mitic LL, Anderson JM. Molecular architecture of tight junctions. Annu Rev Physiol. 1998;60:121–142. [PubMed]
2. Schneeberger EE, Lynch RD. The tight junction: a multifunctional complex. Am J Physiol Cell Physiol. 2004;286:C1213–1228. [PubMed]
3. Coyne CB, Vanhook MK, Gambling TM, Carson JL, Boucher RC, Johnson LG. Regulation of airway tight junctions by proinflammatory cytokines. Mol Biol Cell. 2002;13:3218–3234. [PMC free article] [PubMed]
4. Lee DB, Huang E, Ward HJ. Tight junction biology and kidney dysfunction. Am J Physiol Renal Physiol. 2006;290:F20–34. [PubMed]
5. Fink MP, Delude RL. Epithelial barrier dysfunction: a unifying theme to explain the pathogenesis of multiple organ dysfunction at the cellular level. Crit Care Clin. 2005;21:177–196. [PubMed]
6. Locatelli F, Canaud B, Eckardt KU, Stenvinkel P, Wanner C, Zoccali C. Oxidative stress in end-stage renal disease: an emerging threat to patient outcome. Nephrol Dial Transplant. 2003;18:1272–1280. [PubMed]
7. Lieberthal W, Nigam SK. Acute renal failure. II. Experimental models of acute renal failure: imperfect but indispensable. Am J Physiol Renal Physiol. 2000;278:F1–F12. [PubMed]
8. Bonventre JV, Zuk A. Ischemic acute renal failure: an inflammatory disease? Kidney Int. 2004;66:480–485. [PubMed]
9. Lu CY, Hartono J, Senitko M, Chen J. The inflammatory response to ischemic acute kidney injury: a result of the ‘right stuff’ in the ‘wrong place’? Curr Opin Nephrol Hypertens. 2007;16:83–89. [PubMed]
10. Maenpaa CJ, Shames BD, Van Why SK, Johnson CP, Nilakantan V. Oxidant-mediated apoptosis in proximal tubular epithelial cells following ATP depletion and recovery. Free Radic Biol Med. 2008;44:518–526. [PubMed]
11. Welsh MJ, Shasby DM, Husted RM. Oxidants increase paracellular permeability in a cultured epithelial cell line. J Clin Invest. 1985;76:1155–1168. [PMC free article] [PubMed]
12. Chang YS, Munn LL, Hillsley MV, Dull RO, Yuan J, Lakshminarayanan S, Gardner TW, Jain RK, Tarbell JM. Effect of vascular endothelial growth factor on cultured endothelial cell monolayer transport properties. Microvasc Res. 2000;59:265–277. [PubMed]
13. Leone AK, Chun JA, Koehler CL, Caranto J, King JM. Effect of proinflammatory cytokines, tumor necrosis factor-alpha and interferon-gamma on epithelial barrier function and matrix metalloproteinase-9 in Madin Darby canine kidney cells. Cell Physiol Biochem. 2007;19:99–112. [PubMed]
14. Matter K, Balda MS. Functional analysis of tight junctions. Methods. 2003;30:228–234. [PubMed]
15. Wong V. Phosphorylation of occludin correlates with occludin localization and function at the tight junction. Am J Physiol. 1997;273:C1859–1867. [PubMed]
16. Davies SP, Reddy H, Caivano M, Cohen P. Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem J. 2000;351:95–105. [PubMed]
17. Kang YJ, Seit-Nebi A, Davis RJ, Han J. Multiple activation mechanisms of p38alpha mitogen-activated protein kinase. J Biol Chem. 2006;281:26225–26234. [PubMed]
18. Rhee SG. Cell signaling. H2O2, a necessary evil for cell signaling. Science. 2006;312:1882–1883. [PubMed]
19. Droge W. Free radicals in the physiological control of cell function. Physiol Rev. 2002;82:47–95. [PubMed]
20. Jones DP. Radical-free biology of oxidative stress. Am J Physiol Cell Physiol. 2008;295:C849–868. [PubMed]
21. Tonks NK. Redox redux: revisiting PTPs and the control of cell signaling. Cell. 2005;121:667–670. [PubMed]
22. Coyne CB, Gambling TM, Boucher RC, Carson JL, Johnson LG. Role of claudin interactions in airway tight junctional permeability. Am J Physiol Lung Cell Mol Physiol. 2003;285:L1166–1178. [PubMed]
23. Maltepe E, Saugstad OD. Oxygen in health and disease: regulation of oxygen homeostasis--clinical implications. Pediatr Res. 2009;65:261–268. [PubMed]
24. Virgintino D, Errede M, Robertson D, Capobianco C, Girolamo F, Vimercati A, Bertossi M, Roncali L. Immunolocalization of tight junction proteins in the adult and developing human brain. Histochem Cell Biol. 2004;122:51–59. [PubMed]
25. Balda MS, Whitney JA, Flores C, Gonzalez S, Cereijido M, Matter K. Functional dissociation of paracellular permeability and transepithelial electrical resistance and disruption of the apical-basolateral intramembrane diffusion barrier by expression of a mutant tight junction membrane protein. J Cell Biol. 1996;134:1031–1049. [PMC free article] [PubMed]
26. Meyer TN, Schwesinger C, Ye J, Denker BM, Nigam SK. Reassembly of the tight junction after oxidative stress depends on tyrosine kinase activity. J Biol Chem. 2001;276:22048–22055. [PubMed]
27. Ballabh P, Hu F, Kumarasiri M, Braun A, Nedergaard M. Development of tight junction molecules in blood vessels of germinal matrix, cerebral cortex, and white matter. Pediatr Res. 2005;58:791–798. [PubMed]
28. Zhuang S, Schnellmann RG. A death-promoting role for extracellular signal-regulated kinase. J Pharmacol Exp Ther. 2006;319:991–997. [PubMed]
29. Guyton KZ, Liu Y, Gorospe M, Xu Q, Holbrook NJ. Activation of mitogen-activated protein kinase by H2O2. Role in cell survival following oxidant injury. J Biol Chem. 1996;271:4138–4142. [PubMed]
30. Zhuang S, Kinsey GR, Yan Y, Han J, Schnellmann RG. Extracellular signal-regulated kinase activation mediates mitochondrial dysfunction and necrosis induced by hydrogen peroxide in renal proximal tubular cells. J Pharmacol Exp Ther. 2008;325:732–740. [PubMed]
31. Furuse M, Hirase T, Itoh M, Nagafuchi A, Yonemura S, Tsukita S. Occludin: a novel integral membrane protein localizing at tight junctions. J Cell Biol. 1993;123:1777–1788. [PMC free article] [PubMed]
32. Saitou M, Furuse M, Sasaki H, Schulzke JD, Fromm M, Takano H, Noda T, Tsukita S. Complex phenotype of mice lacking occludin, a component of tight junction strands. Mol Biol Cell. 2000;11:4131–4142. [PMC free article] [PubMed]
33. Van Itallie CM, Anderson JM. Claudins and epithelial paracellular transport. Annu Rev Physiol. 2006;68:403–429. [PubMed]
34. Barrios-Rodiles M, Brown KR, Ozdamar B, Bose R, Liu Z, Donovan RS, Shinjo F, Liu Y, Dembowy J, Taylor IW, Luga V, Przulj N, Robinson M, Suzuki H, Hayashizaki Y, Jurisica I, Wrana JL. High-throughput mapping of a dynamic signaling network in mammalian cells. Science. 2005;307:1621–1625. [PubMed]
35. Gonzalez-Mariscal L, Betanzos A, Nava P, Jaramillo BE. Tight junction proteins. Prog Biophys Mol Biol. 2003;81:1–44. [PubMed]
36. Basuroy S, Seth A, Elias B, Naren AP, Rao R. MAPK interacts with occludin and mediates EGF-induced prevention of tight junction disruption by hydrogen peroxide. Biochem J. 2006;393:69–77. [PubMed]
37. Kiely B, Feldman G, Ryan MP. Modulation of renal epithelial barrier function by mitogen-activated protein kinases (MAPKs): mechanism of cyclosporine A-induced increase in transepithelial resistance. Kidney Int. 2003;63:908–916. [PubMed]
38. Lipschutz JH, Li S, Arisco A, Balkovetz DF. Extracellular signal-regulated kinases 1/2 control claudin-2 expression in Madin-Darby canine kidney strain I and II cells. J Biol Chem. 2005;280:3780–3788. [PubMed]
39. Fischer S, Wiesnet M, Renz D, Schaper W. H2O2 induces paracellular permeability of porcine brain-derived microvascular endothelial cells by activation of the p44/42 MAP kinase pathway. Eur J Cell Biol. 2005;84:687–697. [PubMed]
40. Kevil CG, Oshima T, Alexander B, Coe LL, Alexander JS. H(2)O(2)-mediated permeability: role of MAPK and occludin. Am J Physiol Cell Physiol. 2000;279:C21–30. [PubMed]
41. Patrick DM, Leone AK, Shellenberger JJ, Dudowicz KA, King JM. Proinflammatory cytokines tumor necrosis factor-alpha and interferon-gamma modulate epithelial barrier function in Madin-Darby canine kidney cells through mitogen activated protein kinase signaling. BMC Physiol. 2006;6:2. [PMC free article] [PubMed]
42. Singh AB, Harris RC. Epidermal growth factor receptor activation differentially regulates claudin expression and enhances transepithelial resistance in Madin-Darby canine kidney cells. J Biol Chem. 2004;279:3543–3552. [PubMed]
43. Han J, Lee JD, Bibbs L, Ulevitch RJ. A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells. Science. 1994;265:808–811. [PubMed]
44. Lee JC, Laydon JT, McDonnell PC, Gallagher TF, Kumar S, Green D, McNulty D, Blumenthal MJ, Heys JR, Landvatter SW, et al. A protein kinase involved in the regulation of inflammatory cytokine biosynthesis. Nature. 1994;372:739–746. [PubMed]
45. Pearson G, Robinson F, Beers Gibson T, Xu BE, Karandikar M, Berman K, Cobb MH. Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions. Endocr Rev. 2001;22:153–183. [PubMed]
46. Kevil CG, Oshima T, Alexander JS. The role of p38 MAP kinase in hydrogen peroxide mediated endothelial solute permeability. Endothelium. 2001;8:107–116. [PubMed]
47. Oshima T, Sasaki M, Kataoka H, Miwa H, Takeuchi T, Joh T. Wip1 protects hydrogen peroxide-induced colonic epithelial barrier dysfunction. Cell Mol Life Sci. 2007;64:3139–3147. [PubMed]
48. Hallman MA, Zhuang S, Schnellmann RG. Regulation of dedifferentiation and redifferentiation in renal proximal tubular cells by the epidermal growth factor receptor. J Pharmacol Exp Ther. 2008;325:520–528. [PubMed]
49. Zhuang S, Yan Y, Han J, Schnellmann RG. p38 kinase-mediated transactivation of the epidermal growth factor receptor is required for dedifferentiation of renal epithelial cells after oxidant injury. J Biol Chem. 2005;280:21036–21042. [PubMed]